At MalariaWorld we work with partners. One of the advantages of partnering with MalariaWorld is that we use our 20+ years of knowledge, skills, and experience as well as our entire MalariaWorld network to get information across to more than 11.000 malaria professionals in 140 countries. How do we do that? Well, sometimes we just partner for a certain event such as with MIM, PAMCA, or the First Malaria World Congress.
In 2012, the following remark appeared in the Journal of Travel Medicine (reference 44 in the publication for which the link is provided below):
"Malariologists need to reassess the conventional view that plasmodial habitats in humans are only liver and blood and be more open to the concept of there perhaps being additional parasite reservoirs."
World Health Organization, 3 September 2021
In 2017, WHO warned that the global response to malaria had reached a crossroads. After 15 years of success in global malaria control, progress had levelled off, and many countries with a high burden of the disease were losing ground.
Watch below the recording of this webinar. Findings from the year-long "Rethinking Malaria" global consultation will be shared along with lessons learned from elimination countries and discussions related to research perspectives; public policy, political, and advocacy perspectives; and programmatic perspectives.
Watch below the recorded webinar "How to Tackle the Challenge of Insecticide and Drug Resistance with Innovative Approaches" with Alfred Amambua-Ngwa and Nathalie Amvongo Adjia, moderated by Abdoulaye Djimdé.
'Eliminating malaria through science' is the mission of the Johns Hopkins Malaria Research Institute (JHMRI) at the Bloomberg School of Public Health. Comprised of world-class scientists, a community-based research program in malaria-prone regions, and a spirit of interdisciplinary investigation, the institute generates transformative scientific results leading us closer to a malaria-free world.
African medical doctors have discovered that infusions of Artemisia afra administered during 20 days definitely and totally cured tuberculosis, even for patients where drugs administred in conformity with the WHO protocol had failed. We quote one of their papers hereafter, but they have run dozens of similar successfull treatments in several countries of the region of the Great Lakes in Africa.
By APLMA, 16 August 2021
In December 2020, with Pakistan in the grips of the pandemic, 8,000 volunteers in the country’s restive tribal region managed to distribute nearly 1.5 million mosquito nets to more than half a million households in the country’s remote tribal areas without contracting a single known case of COVID-19. How they did it offers a valuable lesson about how health authorities, by collaborating with communities and other stakeholders, can keep new health threats from disrupting the ongoing battle against other life-threatening diseases, including malaria.
Are you interested in malaria research? Would you like to improve your writing skills? Would you like to attend the PAMCA Conference for free? Here is your opportunity: volunteer as MESA Correspondent to report from the 2021 virtual PAMCA Conference and Exhibition!
MalariaWorld is a project of the Dutch Malaria Foundation, a charitable organisation that supports innovative ways to fight malaria and makes existing knowledge and information about fighting malaria available to stakeholders all over the world.
A new session of our monthly MESA Webinars: Science for Malaria Impact will be held on September 7 at 2 PM CAT (8 AM EDT, 8 PM SGT).
By Fredros Okumu, 19 August 2021
MOSQUITOES spread diseases to millions of people around the world, yet they remain poorly understood by most. Studying their biology and behaviors can help us combat, and eventually eliminate, dangerous diseases such as malaria and dengue fever.
Watch below the recording of the Masterclass "Malaria Strategies" with Prof. Marcel Tanner
Ifakara MasterClasses in Public Health & Medical Entomology. Episode XXX: Thursday, August 12th 2021
Topics:
Are you interested in malaria research?
Would you like to improve your writing skills?
And, last but not least, would you like to attend the ASTMH annual meeting for free?
Here is your opportunity: volunteer as MESA Correspondent to report from the last four sessions of the MESA Webinars: Science for Malaria Impact!
Watch below the recording of the Masterclass "Malaria Meds" with Profs. Timothy Wells, Pierre Hugo, George Jagoe & Abdoulaye Djimde
Ifakara MasterClasses in Public Health & Medical Entomology. Episode XXIX: Thursday, August 5th 2021.
Topics:
By Lizette Koekemoer, Wits Research Institute For Malaria
It is with great sadness that we have to share with you that Prof Richard Hunt passed away on the 18th of June 2021. This is indeed a huge loss for entomology on the African continent and our hearts goes out to Maureen and Tammy for their loss. Richard was one of the true field entomologists of his time and has trained many of us in the past. RiP
Watch below the recording of the Masterclass "Vectors Asia, Africa & the Americas" with S. Manguin, I. Vythilingam, Y. Rubio Palis, L. Koekemoer
Ifakara MasterClasses in Public Health & Medical Entomology. Episode XXVIII: Thursday, July 8th 2021
Topics:
New report spells out double dividend for accelerating ending malaria and advancing gender equality. As patients, caregivers and providers, women and adolescent girls in malaria-endemic countries are leading investors in the malaria fight, yet systemic gender inequalities also cause them to bear the societal, health and economic burdens of the disease.
Mutaz Akkawi, Pascal Gisenya, Jérôme Munyangi, Pierre Lutgen
…or the key of malaria transmission.
Already 25 years ago it was known that malaria pigment (hemozoin, Hz, biocrystallized heme) is not an inert material. Crude pigment, as present in infected erythrocytes and shed after schizont rupture, may be considered the 'natural diet' ingested by macrophages in infected blood. Hemozoin is a powerful source of radicals, necrosis factor-alpha, interleukins 1 and 6.
Sanaria® PfSPZ-CVac vaccine protected 100% of six subjects against a genetically distant variant parasite strain for 3 months, the first time that such complete protection has ever been achieved for such a long period. Results set the scene for development of a traveler’s vaccine, seasonal malaria vaccinations and genetically attenuated parasites that do not fully develop in the liver through to early blood stage.
Watch below the recording of the Masterclass "Malaria Maps and Models" with Profs. S. Bhatt, S. Kiware, L. Tusting & J. Gerardin
Ifakara MasterClasses in Public Health Research & Practice. Episode XXVII: Thursday, July 1st 2021
Topics:
Findings published in Nature offer potential for use by travelers and prevention of malaria in African populations in near future
ROCKVILLE, MD, USA – June 30, 2021 – Researchers from Sanaria® Inc. and the National Institutes of Health (NIH) are making progress in the development of highly protective malaria vaccines.
In an article published today in Nature, Sanaria’s PfSPZ-CVac (CQ) vaccine is reported as being safe and protecting 100% of six subjects against a variant malaria parasite three months after their last dose in the company’s Phase 1 safety and efficacy trial. This is the first time complete protection against a variant malaria parasite has ever been achieved that long after vaccine administration.
The Malaria Eradication Scientific Alliance (MESA) is seeking volunteers as MESA Correspondents to report from the online MESA Webinars: Science for Malaria Impact. The webinars will be held every first Wednesday of the month starting in May until December and will last 1h starting at 2:00 pm CEST.
The third session of our monthly MESA Webinars: Science for Malaria Impact will be held on July 7 at 2 PM CAT (8 AM EDT, 8 PM SGT). Focusing on genomics, the third webinar will feature Christian Happi, Professor of Molecular Biology and Genomics and Director of the World Bank funded African Center of Excellence for Genomics of Infectious Diseases (ACEGID), in Redeemer’s University, Nigeria, and Stella Chenet Carrasco, Professor at the National University Toribio Rodríguez de Mendoza (UNTRM), Peru.
Watch below the recording of the Masterclass "Two Billion Mosquito Nets & Counting" with Prof. Christian Lengeler from Swiss TPH.
Ifakara MasterClasses in Public Health Research & Practice. Edition XXVI: Thursday, June 24th 2021
Topics:
Mutaz Akkawi, Jerome Munyangi, Pierre Lutgen
Already 200 years ago malaria pigment, later called hemozoin, was discovered.
Virchow, R. Zur pathologischen Physiologie des Bluts. Archiv f. pathol. Anat. 1, 547–563 (1847). https://doi.org/10.1007/BF02114475
COVID-19 has placed a strain on health systems globally. Last March 2020, APMEN held a session at an early stage in the pandemic, where we explored how countries in the Asia Pacific region were going about sustaining malaria services despite the nascent health crisis of COVID-19. A year on, as we are still very much dealing with the pandemic and rolling out the vaccine progressively, we take stock on the region’s ongoing challenges and successes in keeping malaria under check.
Watch below the recording of the MESA webinar "New Approaches to Improve Malaria Mosquito Surveillance and Control", featuring Fredros Okumu, director of science at the Ifakara Health Institute (IHI) in Tanzania, and Mercy Opiyo, medical entomologist at the Manhiça Health Research Centre (CISM) in Mozambique and the Barcelona Institute for Global Health (ISGlobal) in Spain.
ROCKVILLE, MD, USA - June 8, 2021 - The PfSPZ malaria vaccines of Sanaria Inc. are unique in vaccine development as they are composed of weakened (attenuated) forms of the live parasite cells that cause malaria. These parasite cells are called eukaryotic cells and there are no vaccines against any infectious disease composed of such cells. Furthermore, there are no licensed vaccines against any infectious disease caused by a eukaryotic pathogen.
World Health Organization, 28 May 2021
The World Health Assembly, the main governing body of the World Health Organization, has adopted a new resolution that aims to revitalize and accelerate efforts to end malaria, a preventable and treatable disease that continues to claim more than 400 000 lives annually.
